SIBIONICS und PharmaSens erkunden auf der EASD 2026 neue Horizonte für die automatisierte Insulinabgabe

ConferencePositive

AI Analysis

Summary

SiBionics and PharmaSens presented their vision for automated insulin delivery integrated with continuous glucose monitoring technology at the EASD 2026 conference, showcasing their collaborative approach to diabetes care.

Importance:3/10

Sentiment:

0.30

diabetesautomated insulin deliverycontinuous glucose monitoringEASD 2026partnership

Read the original article

Published by PR Newswire Clinical Trials on October 5, 2026 2:54 AM

Read Original